Connected CONTOUR® Solution
A guiding light for people managing diabetes and their healthcare professionals, with easy access to reliable blood glucose data1
Providing convenient tools and a better understanding of blood glucose patterns2
CONTOUR®DIABETES app automatically* and seamlessly shares data with healthcare professionals via GlucoContro.online
Benefits of the Connected CONTOUR® Solution
Consistent colour coding for quick and easy interpretation,3,4 which can save time and simplify conversations5
Highly accurate readings you can trust1 to help guide treatment decisions
Easy sign-up process, patients can allow seamless access to data with no additional steps for healthcare professionals
Less dependency on hand written diaries
No need to upload data during consultations†
Data are securely stored in the CONTOUR®CLOUD
Connecting people with diabetes to their healthcare professionals
Healthcare professionals
Sign up to GlucoContro.online
and invite your patients to share their data at GlucoContro.online
Getting started guide for Healthcare Professionals
Getting started guide for people with diabetes
People with diabetes
Download the CONTOUR®DIABETES app** and use the same credentials to log into GlucoContro.online to share your data
Find out more
SdNcenter is the legal manufacturer and developer of GlucoContro.online and is partnering with Ascensia to market and deliver the tool to HCP and Patient users
* Patients need to be registered in GlucoContro.online and approve sharing their data with their healthcare professional
** For a list of compatible devices, please visit compatibility.contourone.com
† Data can still be uploaded from a non-connected meter. Cable connection and Bluetooth connections are both possible for the full range of Contour® portfolio of BGMSs
‡ Terms and conditions apply
References:
- CONTOUR®NEXT (Connected) User Guide, Rev. 05/19 (v0.2).
- Fisher W et al. User Experience With the Information–Motivation–Behavioral Skills (IMB)–Based CONTOUR®NEXT ONE Smart Meter and App System (v0.1). Poster presented at the 78th Scientific Session of the American Diabetes Association (ADA); June 22-26, 2018; Orlando, Florida.
- Bergenstal et al. J Diabetes Sci Technol. 2022;16(1);3–6.
- Al Hayek et al. Cureus 2020;12(10);e11195.
- Mullen et al. J Diabetes Sci Technol. 2018;12(3);614–621.